Litcius/Paper detail

Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?

David Martínez‐Cuadrón, Josefina Serrano, Cristina Gil, Mar Tormo, Pilar Martínez‐Sánchez, José Antonio Pérez‐Simón, Raimundo García‐Boyero, Carlos Rodríguez‐Medina, Maria López‐Pavía, Celina Benavente, Juan Bergua, Esperanza Lavilla, María Luz Amigo, Pilar Herrera, Juan Manuel Alonso‐Domínguez, Teresa Bernal, Mercedes Colorado, María José Sayas, Lorenzo Algarra, María‐Belén Vídriales, Gabriela Rodríguez‐Macías, Susana Vives, Manuel Pérez‐Encinas, Aurelio López, Víctor Noriega, María García‐Fortes, Fernando Ramos, Juan Ignacio Rodríguez-Gutiérrez, Lisette Costilla-Barriga, Jorge Labrador, Blanca Boluda, Rebeca Rodríguez‐Veiga, Joaquín Martínez‐López, Miguel Á. Sanz, Pau Montesinos

2020Leukemia32 citationsDOI

Topics & Concepts

MedicineInternal medicineAdverse effectClinical trialIntensive careIntensive care medicineAcute Myeloid Leukemia ResearchHistone Deacetylase Inhibitors ResearchMyeloproliferative Neoplasms: Diagnosis and Treatment
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing? | Litcius